SMMT — Summit Therapeutics Inc.
1 mentions in the last 24 hours · 0.0% of all mentions
SMMT — 오늘 왜 언급됐나 (2026-10-24)
- 서밋 테라퓨틱스와 루닛은 AI 기반 SCOPE IO 플랫폼 적용을 위한 연구 계약을 발표했습니다.
- 주요 목적은 ivonescimab 프로그램의 바이오마커 발견 및 환자 선정을 위한 것입니다.
Why people talked about SMMT
- Summit Therapeutics and Lunit announced a research agreement to apply the AI-powered SCOPE IO platform.
- The partnership aims to analyze tumor microenvironment in immuno-oncology development using H&E whole-slide images.
- The collaboration focuses on biomarker discovery and patient selection for the ivonescimab program.
| Bluesky | 1 | community |